马达 倪海滨 张晓震

    [摘要] 社区获得性肺炎(Community scquired pneumonia，CAP)临床较为常见，对CAP患者进行疾病严重程度分级评估是合理治疗的基础，尽早识别、全面评价CAP严重程度具有积极的临床意义。重症肺炎患者死亡率更高、住院费用更多，如何降低社区获得性肺炎的重症转化率、减轻患者经济负担是临床治疗常常要面对的难题。使用临床评分量表和(或)生物标志物对需要住院治疗或入住重症监护病房(Intensive care unit，ICU)的高危患者进行早期评估并积极干预有利于改善其生存率并实现社会资源的有效利用。本文针对近些年来不同评分量表及生物标志物在CAP患者病情中的评估作用进行了综述研究。

    [关键词] 社区获得性肺炎;评分量表;生物标志物;预后;重症监护病房

    [中图分类号] R563.1? ? ? ? ? [文献标识码] A? ? ? ? ? [文章编号] 1673-9701(2021)11-0188-05

    Research progress of scoring scale and biomarkers in evaluating community-acquired pneumonia

    MA Da1? ?NI Haibin2? ?ZHANG Xiaozhen2

    1.The Third Clinical Medical College， Nanjing University of Chinese Medicine， Nanjing? ?210046， China; 2.Emergency Department， Affiliated Hospital of Integrated Traditional Chinese and Western Medicine， Nanjing University of Traditional Chinese Medicine， Nanjing? ?210028， China

    [Abstract] Community-acquired pneumonia (CAP) is clinically common. Grading and evaluating the severity of disease in patients with CAP is the basis for reasonable treatment. Early identification and comprehensive evaluation of the severity of CAP has positive clinical significance. Patients with severe pneumonia have a higher mortality rate and more hospitalization costs. How to reduce the severe conversion rate of community-acquired pneumonia and the economic burden of patients is a difficult problem that clinical treatment often faces. The use of clinical scoring scales and/or biomarkers for early assessment and active intervention of high-risk patients who need to be hospitalized or admitted to an intensive care unit (Intensive care unit ......